STD PCHD Overview and Logic Model

Att 3 STD PCHD Overview and Logic Model.pdf

Performance Measures Project

STD PCHD Overview and Logic Model

OMB: 0920-1282

Document [pdf]
Download: pdf | pdf
PS19-1901 Sexually Transmitted Disease Prevention and
Control for Health Departments (STD PCHD)
CDC’s Division of STD Prevention supports 59 state, local, and territorial health departments to conduct STD surveillance,
prevention, and control through the PS19-1901 STD PCHD cooperative agreement.

Purpose and focus
▪
▪

To prevent and control three major STDs: chlamydia (CT), gonorrhea (GC), and syphilis
To contribute towards the following national aims:
Elimination of congenital syphilis
Prevention of antibiotic resistant gonorrhea
Reduction of primary and secondary syphilis

▪

Prevention of STD-related reproductive health problems
Effective response to STD-related outbreaks
Reduction of STD-related health disparities

Priority populations include adolescents and young adults, men who have sex with men, and pregnant women

Strategies
▪
▪
▪
▪

Represent a core program of STD prevention and control for health department STD programs
Are organized into five Strategy Areas, with surveillance as the top priority, followed by disease investigation
and the promotion of CDC-recommended clinical prevention services
Affirm the need for recipients to tailor and prioritize their work to their own context
Promote collaboration with CDC-funded HIV programs, National Network of STD Prevention Training Centers,
and National Coalition of STD Directors, and various other federally-funded and non-governmental partners at
national, state, and local level

Administration
▪

Total 2019 funding was $92,500,000, with awards ranging from $300,000 to over $7,000,000, calculated from a
funding formula based on population and STD morbidity

▪
▪
▪

Recipients include the 50 states, District of Columbia, Puerto Rico, US Virgin Islands, Los Angeles (CA), San
Francisco (CA), Baltimore (MD), Philadelphia (PA), New York City (NYC), Chicago (IL)
Period of performance runs 5 years, from January 1, 2019-December 31, 2023
DSTDP’s Program Development and Quality Improvement Branch (PDQIB) administers the cooperative
agreement, in collaboration with numerous other Branches in the Division

STD PCHD Logic Model
Strategy Areas
Conduct
surveillance

Conduct disease
investigation and
intervention

Promote CDCrecommended
screening,
diagnosis, and
treatment

Promote STD
prevention and
policy

Analyze and use
data for program
improvement

Short-term outcomes
Improved completion and
timeliness of data on reportable
STDs
Faster response to STD
transmission increases and
outbreaks by STD programs

Intermediate outcomes
Increased targeting of high impact
STD prevention and care resources
and activities
Reduced outbreak-related STD
transmission

Increased treatment of cases and
their partners

Increased use of STD, HIV, and
other services by cases and
partners

Increased identification of persons
living with HIV

Increased offering of EPT by
providers

Increased knowledge and skills to
offer expedited partner therapy
(EPT) by targeted providers
Increased knowledge and skill to
use recommended screening,
diagnosis, and treatment practices
by targeted providers

Increased use of EPT by partners

Increased screening for STDs
Increased diagnosis of STDs
Increased use of recommended,
timely treatment
Increased identification of persons
living with HIV

Increased knowledge of STDs and
STD services by public and provider
community
Stronger STD program role in
policy discussions

More efficient targeting of STD
prevention and care resources and
services by STD programs

Increased use of STD services by
public
Improved STD clinical and
reporting practices
Improved health department
policies for STD prevention
Increased effectiveness of high
impact STD prevention and control
activities

Long-term outcomes
Increased effectiveness,
efficiency, and impact of
STD prevention
Reduced STD
transmission and related
adverse health
outcomes
Reduced HIV
transmission

Reduced STD
transmission and related
adverse health
outcomes
Reduced risk of
gonorrhea antibiotic
resistance
Reduced HIV
transmission
Reduced STD
transmission and related
adverse health
outcomes

Increased effectiveness,
efficiency, and impact of
STD prevention


File Typeapplication/pdf
AuthorCarter, Marion (CDC/OID/NCHHSTP)
File Modified2020-01-22
File Created2020-01-22

© 2024 OMB.report | Privacy Policy